NEW YORK, NY / ACCESSWIRE / January 10, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a ...
Hosted on MSN3d
AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell?AstraZeneca AZN stock has declined 14% in the past three months. A lot of this price decline is due to ongoing investigations ...
Shares of AstraZeneca PLC AZN inched up 0.81% to £107.54 Wednesday, on what proved to be an all-around positive trading ...
SAN DIEGO, CA / ACCESSWIRE / January 9, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...
Johnson & Johnson’s combination of Rybrevant and Lazcluze has racked up an overall survival (OS) victory against ...
Analysis of AstraZeneca's market potential, including China and IRA impacts, and the importance of key readouts in 2025 for ...
The ADR's fall snapped a three-day winning streak.
IT worker can continue legal battle against pharmaceutical giant after judge rules that impact of skin condition makes him a ...
Novo Nordisk's prospects look attractive despite a recent clinical setback. AstraZeneca would be performing well if not for ...
Finally, the AstraZeneca class action lawsuit alleges that on December 18, 2024, Financial Times published an article ...
AstraZeneca has been taking a wider role in Vietnam’s healthcare sector to help expand access to quality healthcare.
AstraZeneca PLC AZN shares inched down 0.41% to £106.68 Tuesday, on what proved to be an all-around rough trading session for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback